ABC transporters expressed in the blood–brain interfaces, the BBTB, and cancerous cells represent a selective barrier hindering the delivery of chemotherapeutics to gliomas and contribute importantly to their multidrug resistance, which is one of the causes of their high morbidity and mortality. The gene discussed is ABCG2; the disease is central nervous system cancer.